Somebody told you to “get rid of the bad bacteria.” Then you read that one of those bad ones is in almost every healthy baby. So which is it?
Both can be true. In the gut, the same microbe can help, sit quietly or cause trouble. Here is what decides it, with the research behind each example.
Short answer
Yes, a “bad” bacterium can be harmless or even useful. Strain, amount, location and host decide which way it goes.
Most E. coli help with digestion and vitamins. Most infants carry C. difficile with no ill effects. One B. fragilis molecule protected mice from colitis while toxin-making strains of the same species are linked to diarrhea. The goal is a balanced gut community, not a sterile one.
This is general wellness information, not medical advice. It does not diagnose anything. If your gut symptoms worry you, talk with a qualified healthcare provider.
Flore data
What we see in our own microbiome reports
Start with our data. Among 7,299 people with de-identified reports and symptom records:
- Bacteroides fragilis was flagged above our reference range for 26.5% of people (1,934 of 7,299). That includes 22.9% of people with no digestive complaints (245 of 1,070) and 30.1% of people who reported frequent diarrhea (346 of 1,148).
- E. coli was flagged for 13.6% of people with no digestive complaints (146 of 1,070) and 19.5% of people reporting frequent diarrhea (224 of 1,148).
So these “bad” names lean toward people with symptoms, on average. They also show up in plenty of people who feel fine. A report flag can’t tell a helpful strain from a toxin-making one. That is why one name never tells the whole story.
How we ran these numbers: Flore has analyzed 23,000+ microbiome reports. This section uses the 7,299 people whose de-identified records include both report flags and the symptoms they told us about. A “flag” means a microbe was above our reference range in that person’s stool report. It is not a diagnosis. Symptoms are self-reported. “No digestive complaints” means people who reported other concerns (such as mood, skin or energy) but none of our digestive tags. These are people who came to Flore, not a random sample of the public. Groups under 20 people are never reported. Every figure is an association, not proof of cause.
Good and bad are roles, not species
The gut is crowded. An adult carries roughly 38 trillion bacteria, most of them in the colon (Sender, Fuchs and Milo, 2016). Researchers have a word for residents that are normally fine but can contribute to problems when conditions change: pathobionts. Chow, Tang and Mazmanian described them as microbes “found in most healthy hosts” that may trigger trouble when genetics or environment tip the balance (2011).
That framing changes the question. You stop asking “is this bug bad?” and start asking “what is this bug doing, here, in me, right now?” For the four questions that sort it out, read how to know when a gut bacterium is bad.
Example 1: E. coli, mostly a helper
E. coli gets the headlines. The CDC’s own summary: “Most E. coli are harmless and are part of a healthy intestinal tract.” They help digest food, produce vitamins and guard against harmful germs. Some types cause diarrhea, urinary tract infections and other illnesses (CDC). The species is the same. The strain and the location decide the outcome.
Example 2: C. difficile, quiet in babies
C. difficile is a leading cause of antibiotic-associated diarrhea (Crobach et al., 2018). It is also carried by about 60% to 70% of healthy newborns and infants, who “show no ill effects” (Jangi and Lamont, 2010). Most children lose it between 12 and 24 months as their adult gut community develops. The antibody response that forms during that carrier stage “appears to provide durable protection” against later C. diff disease (Jangi and Lamont, 2010).
In adults, the CDC notes that most infections “occur while or soon after taking antibiotics,” and that people taking antibiotics face up to ten times the risk (CDC). The microbe did not change. Its competition did.
Example 3: Bacteroides fragilis, one species, two stories
B. fragilis is a common gut resident. In a well-known mouse study, a single molecule it makes, polysaccharide A, protected the animals from colitis triggered by another gut bacterium. B. fragilis that could not make the molecule did not protect them (Mazmanian, Round and Kasper, 2008). That was in mice, and it shows how a resident microbe can help keep inflammation in check.
Meanwhile, certain strains of the same species make a toxin. Those enterotoxigenic B. fragilis strains are linked to diarrheal disease in children and adults (Sears, 2009). Same name, opposite roles.
Example 4: normal bacteria in the wrong place
Bacteria that belong in your colon can cause symptoms when they build up in the small intestine. That is small intestinal bacterial overgrowth, or SIBO (ACG, 2020). The bacteria are usually ordinary colon residents. The problem is where they are and how many. Read more in SIBO: when normal gut bacteria end up in the wrong place.
What this means for your gut
- Don’t panic over one name. A microbe on a report is a data point. Strain, amount and location matter more.
- Don’t chase sterile. Clearing out gut bacteria can open the door for the ones you least want. Most C. diff infections follow antibiotics (CDC). Take antibiotics when your clinician prescribes them, and not otherwise.
- Look at the whole community. Healthy people carry different gut communities (HMP Consortium, 2012). Your baseline is your own.
Where Flore fits
This is why Flore starts with your data. An at-home gut microbiome test shows your whole community, helpers and troublemakers in context. Flore then builds a personalized probiotic-and-prebiotic formula to support that community, and you retest so the next formula reflects what changed. See how Flore builds a formula from microbiome data. It is wellness support, not a diagnosis or a treatment for any condition.
Flore (formerly Sun Genomics) builds personalized probiotics from your own gut microbiome. Your sample is read by a CLIA-certified partner lab. Flore builds and makes your formula from the results. That work spans 10 years, 18,700+ people served, 23,000+ microbiome reports analyzed and 40,000+ personalized formulations.
Educational, structure/function information. Not medical advice, and not intended to diagnose, treat, cure or prevent any disease.
Frequently asked questions
Can bad bacteria be good?
Sometimes. Many microbes with a bad reputation live quietly in healthy people, and some do useful work. Most E. coli are harmless and help digest food, make vitamins and guard against harmful germs (CDC). Whether a microbe helps or harms depends on the strain, the amount, the location and the host.
Is C. diff always harmful?
No. About 60% to 70% of healthy newborns and infants carry C. difficile with no ill effects, and the antibody response that develops during this carrier state appears to protect against later C. diff disease (Jangi and Lamont, 2010). In adults, most C. diff infections happen while or soon after taking antibiotics (CDC).
Is Bacteroides fragilis good or bad?
Both, depending on the strain. In mice, a molecule made by B. fragilis called polysaccharide A protected against experimental colitis (Mazmanian, Round and Kasper, 2008). Toxin-making strains, called enterotoxigenic B. fragilis, are linked to diarrheal disease in people (Sears, 2009).
Should I try to kill the bad bacteria in my gut?
Wiping out gut bacteria can backfire. Most C. diff infections happen while or soon after taking antibiotics, and people are up to 10 times more likely to get one while on an antibiotic (CDC). Take antibiotics when your clinician prescribes them. For everyday gut support, the goal is a balanced community, not a sterile one.
What is a pathobiont?
A pathobiont is a normal resident of the gut that can contribute to problems when conditions change, such as genetics, immune function or environment. The term separates these residents from infectious agents picked up from outside (Chow, Tang and Mazmanian, 2011).
Get the free Gut Health Field Guide
Plain-English science, no hype. We’ll send occasional gut-health guides and Flore updates. Unsubscribe anytime.
Read the Gut Health Field Guide now → No signup needed.
By subscribing you agree to receive email from Flore. This is general wellness information, not medical advice.
Curious which microbes are doing what in your gut?
Flore’s test-to-treat program starts with an at-home gut test read by an accredited partner lab, then builds a probiotic-and-prebiotic formula from your data. Retest, and the next formula is built from the new read. Wellness insight into your gut, not a medical diagnosis.
See how test-to-treat works →
Sources
- Flore internal analysis of de-identified, aggregated report flags and self-reported symptoms, 7,299 people, November 2026. Groups under 20 not reported. Associations only.
- CDC: About E. coli (Escherichia coli)
- CDC: About C. diff (May 2026)
- Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr. 2010;51(1):2-7. PMID 20512057
- Crobach MJT, et al. Understanding Clostridium difficile colonization. Clin Microbiol Rev. 2018;31(2):e00021-17. PMID 29540433
- Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008;453(7195):620-625. PMID 18509436
- Sears CL. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev. 2009;22(2):349-369. PMID 19366918
- Chow J, Tang H, Mazmanian SK. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr Opin Immunol. 2011;23(4):473-480. PMID 21856139
- Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. PMID 27541692
- Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207-214. PMID 22699609
- Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020;115(2):165-178. PMID 32023228
Flore was formerly Sun Genomics. This article is general wellness information and is not medical advice, diagnosis or treatment. Statements have not been evaluated by the FDA. Talk to a qualified healthcare provider about your health.